Page 82 - Prostate News Today

The androgen receptor is a key transcriptional factor for the proper sex development —specially in males— and the physiological balance of all the tissues that express this receptor.

NewsMedical exchanges with Cerba Research on how to achieve immune cell checkpoint profiling of solid tumors by multiplex immunofluorescence.

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY) announced positive results from the Phase 3 China ARCHES study of Xtandi (enzalutamide) plus androgen deprivation therapy in men with metastatic hormone-sensitive

Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white.

According to the reports of the largest study, active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery.

Surgeons in Germany have shown a small technical change to keyhole surgery for prostate cancer can more than halve one of the most common post-operative complications – where lymphatic fluid collects in the pelvis.

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today.

Raising awareness of male health: ANDRONET COST Action to improve research, education, and public awareness in the field of andrology.

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. The

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery ...